Therefore, we hypothesized that an exaggerated FcγR mediated activation triggered by SARS-CoV-2 specific IgG might contribute to the exacerbation of COVID-19 in critically compared to severely diseased patients. The gene discussed is FCGR2A; the disease is COVID-19.